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Diazinon poisoning is an important issue in occupational, clinical, and forensic toxicology. While sensitive and specific 
enough to analyse diazinon in biological samples, current methods are time-consuming and too expensive for routine 
analysis. The aim of this study was therefore to design and validate a simple dispersive liquid-liquid microextraction 
(DLLME) for the preparation of urine samples to be analysed for diazinon with high performance liquid chromatography 
with diode-array detector (HPLC-DAD) to establish diazinon exposure and poisoning. To do that, we first identified 
critical parameters (type and volume of extraction and disperser solvents, pH, surfactant, and salt concentrations) in 
preliminary experiments and then used central composite design to determine the best experimental conditions for 
DLLME-HPLC-DAD. For DLLME they were 800 µL of methanol (disperser solvent) and 310 µL of toluene (extraction 
solvent) injected to the urine sample rapidly via a syringe. The sample was injected into a HPLC-DAD (C18 column, 
250×4.6 mm, 5 μm), and the mobile phase was a mixture of acetonitrile and buffer (63:37 v/v, pH 3.2; flow rate: 1 mL/
min). Standard calibration curves for diazinon were linear with the concentration range of 0.5–4 µg/mL, yielding a 
regression equation Y=0.254X+0.006 with a correlation coefficient of 0.993. The limit of detection and limit of 
quantification for diazinon were 0.15 µg/mL and 0.45 µg/mL, respectively. The proposed method was accurate, precise, 
sensitive, and linear over a wide range of diazinon concentrations in urine samples. This method can be employed for 
diazinon analysis in routine clinical and forensic toxicology settings.
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Diazinon (O,O-diethyl O-[4-methyl-6-(propan-2-yl)
pyrimidin-2-yl] phosphorothioate) is one of the most 
common causes of occupational, clinical, and forensic 
organophosphate (OP) poisoning in the world (1–14). In 
biological samples it can be determined with several 
analytical methods for experimental, clinical, and forensic 
purposes (15–18), such as solid-phase extraction (SPE) 
followed by gas chromatography/mass spectrometry (GC/
MS) in postmortem blood samples (15), high performance 
liquid chromatography with diode-array detector (HPLC-
DAD) in serum and urine of patients with acute poisoning 
(16), or liquid chromatography with tandem MS in gastric 
content and blood for forensic toxicology (18).
Although these methods are sensitive, and specific 
enough to analyse diazinon in biological samples, they are 
too time-consuming and expensive for routine analysis. 
This issue has called for the development of simple, fast, 
low-cost, user- and environment-friendly sample preparation 
methods such as liquid phase microextraction (LPME), 
which requires a small volume of a water-immiscible 
solvent (19).
One of the LPME methods is the so called dispersive 
liquid-liquid microextraction (DLLME). It is rapid, simple, 
inexpensive, efficient, and requires minimal (microlitre) 
volumes of low- and high-density solvents for the extraction 
of many water-based samples (20, 21).
However, to obtain optimal efficiency (20–22), this 
method has to be fine-tuned through trial and error, which 
is time-consuming, or through statistical models and 
experimental designs, such as the Taguchi orthogonal array 
design and central composite design (CCD) (23, 24).
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The aim of this study was to make use of experimental 
design and develop a fast, simple, inexpensive and specific 
DLLME-HPLC-DAD method for the determination of 
diazinon in human urine samples for routine analysis in 
clinical and forensic toxicology laboratories.
MATERIALS AND METHODS
Chemicals
HPLC-grade methanol, acetonitrile, water, toluene and 
dichloromethane were purchased from Merck Chemical 
Co. (Darmusdat, Germany). HPLC-grade standards for 
diazinon, pirimiphos-methyl, azinphos-ethyl, and 
chlorpyrifos were purchased from Dr. Ehrenstofer GmbH 
(Augsburg, Germany). All other chemicals and reagents 
were of analytical grade, purchased from Merck Chemical 
Co.
Instrumentation and chromatographic conditions
Separation, identification, and quantification were 
carried out on a Knauer HPLC system (Smartline Series 
1200, Berlin, Germany). Chromatography was run 
isocratically on a Nucleosil® C18 analytical column 
(250×4.6 mm, 5 μm particle size, Perfectsil® Target). An 
RP-18 guard column was fitted upstream of the analytical 
column. The mobile phase was a mixture of acetonitrile 
and buffer, optimised (63:37 v/v, pH 3.2) and delivered by 
a Knauer 1050 HPLC pump at a flow rate of 1 mL/min. A 
diode array detector (K-2800, Knauer) with a wavelength 
range of 190–740 nm was used for detection. The system 
was equipped with ChromGate® software (version 3.3.2., 
Knauer).
Sample preparation
We used diazinon-free urine samples provided by 
healthy volunteers in our laboratory. They were kept frozen 
at -20 °C until analysis and then thawed to room 
temperature. Each sample was added 10 µL of pirimiphos-
methyl (internal standard, IS) (2.5 µg/mL) and vortexed at 
1250xg for 10 min. Then we added 100 µL of sodium lauryl 
sulphate (SLS) (3 % w/v) and 100 µL of sodium chloride 
(NaCl) (1 %,w/v) to the glass tubes containing 1000 µL of 
urine. The final solution was then prepared following the 
DLLME procedure.
DLLME procedure
A mixture of 800 µL of methanol (disperser solvent) 
plus 310 µL of toluene (extraction solvent) was quickly 
injected to the samples with a syringe (Hamilton, NV, USA), 
which dispersed fine droplets of toluene to form a cloudy 
solution. Over just a few seconds, the analytes were 
extracted on toluene droplets and after centrifugation at 
1250xg for 15 min, these droplets became a supernatant on 
the surface of the conical test tube. The supernatant phase 
was then completely transferred into another conical test 
tube and the residue dried by evaporation with nitrogen in 
a water bath, dissolved to a mobile phase, and then 20 µL 
of the sample injected into the HPLC.
DLLME optimisation with experimental design
To achieve maximum recovery, the selection of 
extraction efficiency variables was based on preliminary 
experiments that yielded distinct responses of eight 
variables on three levels of experimental designs (Table 1). 
Optimisation was performed on spiked samples.
Preparation of standard solutions
Standard solutions were prepared by serially diluting 
the diazinon stock solution (100 µg/mL) with HPLC-grade 
water to 0.5, 1.0, 1.5, 2, 2.5, 3, and 4 µg/mL. The stock 
solution (2.5 µg/mL) of pirimiphos-methyl (IS) in methanol 
was prepared and stored at -20 °C. The stock and standard 
solutions were prepared on a daily basis and stored in the 
dark at 4 °C. All solutions were used on the day they were 
prepared.
Experimental design
To obtain optimal conditions, we relied on the four-
factor-two-level central composite design (CCD), which is 
used in response surface methodology. Briefly, each 
numeric factor is varied over five levels: plus and minus 
alpha (axial points), plus and minus 1 (factorial points), and 
the centre point. If categorical factors are added, CCD will 
be duplicated for every combination of the categorical factor 
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Table 1 Variables and their levels for experimental design 
Symbol Level 3 Level 2 Level 1 Factor
A methanol acetonitril type of disperser solvent
B 10 0 sonication duration (minute)
C dichloromethane chloroform toluene type of extraction solvent
D 600 300 100 volume of extraction solvent (µL)
E 1000 500 0 volume of disperser solvent (µL)
F 5 3 1 surfactant concentration (% w/v)
G 5 3 1 salt concentration (% w/v)
H 10 7 4 pH
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levels. It was also used to investigate parabolic interactions 
between the following parameters: volume of extraction 
solvent (toluene), salt percentage (NaCl), surfactant 
percentage (SLS), and the volume of disperser solvent 
(methanol). This CCD design allowed modelling the 
response surface by fitting a second-order polynomial with 
the number of experiments equal to 21 for four factorial 
designs at five levels and five replicated points. Table 2 
shows the range of independent variables used in this study 
in terms of actual and coded values.
HPLC method validation
Validation included the following parameters: linearity, 
precision, accuracy, limits of detection and quantification, 
and selectivity (25). For calibration we used seven 
concentrations ranging from 0.5 to 4 µg/mL of diazinon. 
Each concentration was prepared in triplicate and analysed 
three times. Calibration curves were constructed by plotting 
the concentration of compounds versus peak area response. 
The linearity was evaluated with the least square regression 
method.
The limit of quantification (LOQ) was determined 
during the evaluation of the linear range of calibration curve. 
its actual concentration. The accuracy was expressed with 
recovery percentage.
Selectivity was evaluated by comparing chromatograms 
of different batches of urine spiked with diazinon, IS, 
tramadol, azinphos-ethyl, pirimiphos-methyl, and 
chlorpyrifos.
Data analysis
For regression analysis and diagram plotting for the 
experimental results we used the Design Expert v. 7.01 
software (Stat-Ease Inc., Minneapolis, MN, USA).
Ethical approval
This project was approved by the Ethics Committee of 
the Legal Medicine Research Centre.
RESULTS AND DISCUSSION
Results of DLLME optimisation
Sonication and pH had negative effects on maximum 
recovery (p>0.05). Other parameters had a positive effect 
(p<0.05) and were selected for further optimisation 
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Table 2 Analysis of variance for the proposed model
Source Sum of Squares df Mean square F value p-value* Prob.> F
Model 6195.89 14 442.56 41.69 0.0053
A 2223.78 1 2223.77 206.49 0.0007
B 72.231 1 72.31 6.81 0.0797
C 726.08 2 363.04 34.2 0.0086
D 862 2 431 40.6 0.0067
E 229.05 2 114.52 10.79 0.0426
F 1029.91 2 514.95 48.51 0.0052
G 915.54 2 457.77 43.12 0.0062
H 137.22 2 68.61 6.46 0.0817
Residual 31.85 3 10.62
Correction Total 6227.774 17
* all p-values are statistically significant
Table 3 Experimental ranges and levels of independent variables 
for the central composite design
α- 1- 0 1+ α+
Methanol µL A 200 400 600 800 1000
NaCl % B 0 1 2 3 4
SLS % C 0 1 2 3 4
Toluene µL D 225 300 375 450 525
SLS – sodium lauryl sulphate




where σ is the standard deviation of response, and S is the 
slope of the calibration curve.
The method’s precision was determined by repeatability 
(intra-day) and intermediate precision (inter-day) and was 
expressed as relative standard deviation (RSD). Five 
replicate injections of diazinon standard solutions were 
prepared at concentrations ranging from 0.5 to 4 µg/mL. 
The intra-day variation was assessed on the same day, while 
inter-day precision encompassed three consecutive days. 
Both assessments were carried out by the same analyst.
The accuracy of the method was tested with five 
replicates of three samples containing different diazinon 
concentrations, and the measurements were compared with 
(Table 3). Methanol (as disperser solvent) and toluene (as 
extraction solvent) had positive effects on all variables and 
were used in the experiments.
Response surfacing based on CCD
The actual and statistically predicted diazinon recoveries 
for experiments are shown in Table 4, while Figure 1 shows 
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This equation represents the relationship that diazinon 
recovery (R) has with the volume of the disperser solvent 
(A), salt concentration (B), surfactant concentration (C), 
the volume of extraction solvent (D), and their combinations 
(AB, AC, AD, and BC). Table 5 shows the results of the 
analysis of variance (ANOVA) for the CCD model and the 
significance of each coefficient determined by F-values 
(variation of data about mean value) and P-values 
(probability). The model turned out to be highly predictive 
of the experimental results. Extraction solvent volume had 
a high linear and quadratic effect on response. In addition, 
the interaction effects of combined variables were 
significant. The correctness of the model was also ensured 
by multiple correlation coefficient (R2), which was 0.9872 
and showed high prediction of the actual value and excellent 
response, with 0.85 % of the total variation. The predicted 
R2 (0.8624) was in reasonable agreement with the adjusted 
R2 (0.9716). Furthermore, the coefficient of variance 
(CV=4.76 %) was low, which indicates significant precision 
and reliability of the experimental data.
For precision to be adequate, the signal-to-noise ratio 
should be >4. With our model it was 30.73, indicating that 
it could be used to evaluate experiments.
Figure 2 shows a 3D response surface diagram of the 
effects of two factors on diazinon recovery. Figure 2A shows 
significant interactions of extraction and disperser solvent 
volume with diazinon recovery (p<0.0002). Diazinon 
recovery increased with the increase in extraction solvent 
volume (from 300 to 450 µL) and disperser solvent volume 
(from 400 to 800 µL). Significant increase in diazinon 
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Figure 1 Probability plot of the effects
Table 4 Experimental conditions according to the central composite design and observed response values











1 800 3.00 3.00 300.00 43.70 40.72
2 800 3.00 1.00 300.00 20.10 21.55
3 800 1.00 3.00 450.00 82.00 80.49
4 400 3.00 1.00 450.00 69.27 68.99
5 800 1.00 1.00 450.00 43.52 43.50
6 400 1.00 3.00 300.00 46.3 43.06
7 400 3.00 3.00 450.00 63.00 61.23
8 400 1.00 1.00 300.00 31.80 32.99
9 200 2.00 2.00 375.00 63.00 64.14
10 1000 2.00 2.00 375.00 53.50 54.13
11 600 0.00 2.00 375.00 67.50 67.14
12 600 4.00 2.00 375.00 29.00 28.64
13 600 2.00 0.00 375.00 18.02 15.94
14 600 2.00 4.00 375.00 41.33 45.18
15 600 2.00 2.00 225.00 42.00 42.88
16 600 2.00 2.00 525.00 73.60 74.48
17 600 2.00 2.00 375.00 48.00 47.89
18 600 2.00 2.00 375.00 46.00 47.89
19 600 2.00 2.00 375.00 49.00 47.89
20 600 2.00 2.00 375.00 50.00 47.89
21 600 2.00 2.00 375.00 44.00 47.89
SLS – sodium lauryl sulphate
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Figure 2 Surface plots showing the effects of variables with the highest impact on the recovery of the method
(A) The effect of the volume of toluene and methanol; (B) the effect of the volume of methanol and the sodium lauryl sulphate (SLS) 
concentration; (C) the effect of methanol volume and the sodium chloride (NaCl) concentration
Table 5 Analysis of variance for central composite design
Source Sum of squares df Mean square F value p-value*Prob. > F
Model 840.2 11 76.37 63.10 <0.0001
A 16.28 1 16.28 13.45 0.0052
B 112.89 1 112.89 93.28 <0.0001
C 142.35 1 142.35 117.63 <0.0001
D 70.52 1 70.52 58.27 <0.0001
AB 27.88 1 27.88 23.04 0.0010
AC 53.21 1 53.21 43.97 <0.0001
AD 44.91 1 44.91 37.11 0.0002
BC 19.36 1 19.36 16.00 0.0031
A^2 31.00 1 31.00 25.62 0.0007
C^2 84.41 1 84.41 69.75 <0.0001
D^2 26.72 1 26.72 22.08 0.0011
Residual 10.89 9 1.21
Lack of Fit 7.37 5 1.47 1.67 0.3196
Pure Error 3.53 4 0.88
Cor Total 850.91 20
* all p-values are statistically significant
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recovery was noted when the extraction solvent volume 
reached 310 µL and disperser solvent 800 µL.
Figure 2B shows that the interactions between diazinon 
recovery and disperser solvent volume and surfactant 
concentrations were significant (p<0.0001) at maximum 
surfactant concentration of 3 % and maximum disperser 
solvent volume.
Figure 2C, in turn, shows that diazinon recovery also 
had significant interactions with disperser solvent volume 
when it reached its maximum volume of 800 µL and when 
salt percentage was at its lowest (p<0.001).
Results of method validation
Standard calibration curves for diazinon were linear 
with the concentration range of 0.5–4 µg/mL, yielding a 
regression equation of Y=0.254X+0.006 with a correlation 
coefficient of 0.993. This is generally considered evidence 
of an acceptable fit and good linearity over the concentration 
range.
The method yielded LOD and LOQ of 0.15 µg/mL and 
0.45 µg/mL, respectively, and its precision met the 
acceptance criteria (Table 6). The intra- and inter- day RSD 
values did not exceed 5 % (bias interval between 3.0 and 
5.0 %), which indicates that the method is accurate, reliable, 
and reproducible.
Table 6 also shows that the recovery percentages comply 
with the acceptance criteria (25).
The specificity of the method was tested with peak 
purity on blank and spiked urine samples. Blank samples 
showed no interference when diazinon and IS were added. 
Under optimised conditions, the separation of diazinon and 
pirimiphos-methyl was complete (Figure 3).
Method application in real conditions
The applicability of the proposed DLLME-HPLC-DAD 
method was evaluated in undiluted urine samples collected 
from  patients poisoned with diazinon who were receiving 
hospital treatment (Sanandaj, Iran). Relative diazinon 
recoveries were determined at the spiking level of 0.5, 1, 
and 3 µg/mL. The results of six replicate experiments of 
each sample were in the range of 75–95.6 %. Therefore, 
the proposed method can be applied for determining 
diazinon in human urine samples.
Comparison of the DLLME-HPLC-DAD with other 
methods
Table 7 summarises a comparison of the proposed 
DLLME-HPLC-DAD method with other methods and 
shows that its LOD, R2, and recovery are well within 
acceptable ranges.




Intra-day (n=5) Inter-day (n=5)
Mean±SD CV (%) Recovery±SD (%) Mean±SD CV (%)
Recovery±SD 
(%)
0.5 0.46±0.04 7.4 92.1±1.0 0.48±0.03 6.9 95.6±1.0
1 0.76±0.02 3.3 76.0±2.0 0.75±0.01 1.2 75.0±1.1
3 2.33±0.09 4.0 77.4±0.9 2.31±0.11 4.9 77.1±1.4
Table 7 Comparison of the proposed DLLME-HPLC-DAD with other analytical methods for determination of diazinon in biological 
samples
Method Matrix LOD (µg/mL)
Correlation 
coefficient (R2) Recovery (%) Ref. No.
SPE-GC-MS whole blood 0.15 0.9981 78–87 15
SPE-HPLC-DAD plasma 0.15 0.998 77.7–86.3 17
LLE-HPLC-DAD whole blood, serum, urine 0.78 0.9996
97.4–99.01  
(for blood and serum)
101.1–101.4 (for urine)
16
mini-QuEChERS-LC-MS-MS whole blood, gastric content 0.1 0.95 80–100 18
MEPS-GC-MS-MS whole blood 0.5 0.99 61–77 26
DBS-GC-MS-MS whole blood 0.05 0.998 4.56–5.11 27
DLLME-HPLC-DAD urine 0.15 0.993 75.0–95.6 this study
SPE-GC-MS – solid-phase extraction and gas chromatography/mass spectrometry; SPE-HPLC-DAD – solid-phase extraction and 
high-performance liquid chromatography (HPLC) with diode array detector (DAD); LLE-HPLC-DAD – liquid-liquid extraction and 
high-performance liquid chromatography (HPLC) with diode array detector; mini-QuEChERS-LC-MS-MS – modified quick, easy, 
cheap, effective, rugged and safe (QuEChERS) method – liquid chromatography with tandem mass spectrometry; MEPS-GC-MS-MS 
– microextraction by packed sorbent (MEPS) – gas chromatography-tandem mass spectrometry; DBS-GC-MS-MS – dried blood spot 
(DBS) – gas chromatography coupled to tandem mass spectrometry; DLLME-HPLC-DAD – dispersive liquid- liquid phase 
microextraction-high performance liquid chromatography with diode array detector
54 Mohammadzaheri R et al. Experimental CCD-based DLLME for HPLC-DAD determination of diazinon: method development and validation Arh Hig Rada Toksikol 2020;71:48-55
Figure 3 Specificity of the proposed method for the analysis of diazinon in urine sample
Chromatogram A: blank urine; Chromatogram B: urine spiked with: 1 – tramadol, 2 – azinphos-ethyl, 3 – diazinon, 4 – pirimiphos-
methyl, and 5 – chlorpyrifos
CONCLUSION
Our findings evidence that our DLLME-HPLC-DAD 
is a rapid and simple extraction and determination method 
for diazinon in human urine samples. It overcomes the 
limitations of conventional sample preparation methods 
that involve the use of large volumes of expensive and toxic 
organic solvents. However, it is evident that further studies 
are necessary for different biological specimen in order to 
suppress matrix effects and enhance extraction recoveries. 
The proposed DLLME-HPLC-DAD method is simple, 
cheap, accurate, and sensitive enough to be applied in 
clinical and forensic toxicological analysis.
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Disperzivna tekućinsko-tekućinska mikroekstrakcija temeljena na eksperimentalnom centralnom kompozitnom 
dizajnu u svrhu određivanja diazinona u ljudskoj mokraći: razvoj i validacija metode
Trovanje diazinonom važan je problem za medicinu rada te kliničku i forenzičnu toksikološku praksu. Premda su postojeće 
metode njegova utvrđivanja u biološkim uzorcima dovoljno osjetljive i specifične, njihova je primjena za rutinske analize 
preskupa i dugotrajna. Zbog toga je cilj ovoga istraživanja bio razviti i validirati jednostavnu metodu disperzivne 
tekućinsko-tekućinske mikroekstrakcije (engl. dispersive liquid-liquid microextraction, krat. DLLME) kojom bi se uzorci 
ljudske mokraće pripremili za analizu diazinona tekućinskom kromatografijom visoke djelotvornosti s detektorom s nizom 
fotodioda (engl. high performance liquid chromatography with diode-array detector, krat. HPLC-DAD) radi utvrđivanja 
izloženosti i trovanja diazinonom. U tu smo svrhu u preliminarnim eksperimentima prvo odredili ključne parametre: vrstu 
i volumen ekstrakcijskoga i disperzijskoga otapala, pH, površinski aktivne tvari (surfaktanta) te koncentraciju soli. Zatim 
smo s pomoću eksperimentalnoga centralnoga kompozitnoga dizajna utvrdili optimalne eksperimentalne uvjete za 
DLLME-HPLC-DAD. Za DLLME oni su bili 800 µL metanola (kao disperzijskoga otapala) te 310 µL toluena (kao 
ekstrakcijskoga otapala) za brzu injekciju uzorka mokraće. Uzorak je injektiran u HPLC-DAD (5-mikrometarski analitički 
stupac C18, 250×4,6 mm), a mobilna je faza bila mješavina acetonitrila i pufera (63:37 v/v, pH 3.2; protok: 1 mL/min). 
Standardne su kalibracijske krivulje za diazinon bile linearne s rasponom koncentracija diazinona od 0,5 do 4 µg/mL, a 
regresijska jednadžba Y=0,254X+0,006 s koeficijentom korelacije 0,993. Granice detekcije odnosno kvantifikacije 
diazinona bile su 0,15 µg/mL odnosno 0,45 µg/mL. Ova se metoda pokazala točnom, preciznom, osjetljivom i linearnom 
u širokom rasponu koncentracija diazinona u uzorcima mokraće, stoga se može koristiti za njegovu rutinsku analizu u 
kliničkoj i forenzičnoj toksikološkoj praksi.
KLJUČNE RIJEČI: disperzijsko otapalo; ekstrakcijsko otapalo; mikroekstrakcija tekućinskom fazom; tekućinska 
kromatografija visoke djelotvornosti; Taguchijev ortogonalni niz
